Vesencumab (MNRP-1685A) is an IG1 antibody targeting NRP-1 with anti-angiogenic and anti-tumor activity that reduces the number of globules formed by the SUM159 and Hs578T cell lines. Vesencumab inhibits EGFR and PDGFRalpha activation and can be used to study solid tumors.
Reinheit:
0.992
CAS Nummer:
[1205533-60-3]
Target-Kategorie:
EGFR|||p38 MAPK|||PDGFR|||Complement System
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
